Ischemic brain injury and regulatory t cells

Minako Ito, Tanakorn Srirat, Toshihiro Nakamura, Kyoko Komai, Akihiko Yoshimura

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)

Abstract

Inflammation and immune responses after stroke, including ischemic cerebral infarction, play pivotal roles in the pathology, resolution of inflammation, and neurological recovery. Regulatory T (Treg) cells are the cells responsible for immune tolerance, usually activated by secondary lymphatic tissues, which subsequently regulate effector T cell activation and dendritic cell activation. Recently, Tregs that are present in tissues, called tissue Tregs, have been shown to exhibit tissue-specific functions in addition to immune regulation, contributing to the maintenance of homeostasis and tissue repair. We found that Tregs accumulate in the brain at the chronic phase of ischemic brain injury and control astrogliosis through the secretion of amphiregulin. Unlike other tissue Tregs, brain Tregs express a serotonin receptor (Htr7) that is characteristic of the nervous system, and are proliferated and activated by serotonin. Administering a serotonin or selective serotonin reuptake inhibitor (SSRI) in an experimental stroke mouse model increased the number of brain Tregs and improved neurological symptoms. Elucidation of the significance of brain Tregs should also contribute to the understanding of other types of neuroinflammation.

Original languageEnglish
JournalOBM Neurobiology
Volume3
Issue number1
DOIs
Publication statusPublished - 2019

Keywords

  • Amphiregulin
  • Astrogliosis
  • Ischemic brain injury
  • Regulatory T cell
  • Serotonin
  • SSRI
  • Stroke
  • Tissue Treg

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of 'Ischemic brain injury and regulatory t cells'. Together they form a unique fingerprint.

Cite this